These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21892267)

  • 1. Recent advances in proteomics and cancer biomarker discovery.
    Xiao GG; Recker RR; Deng HW
    Clin Med Oncol; 2008; 2():63-72. PubMed ID: 21892267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New cancer biomarkers deriving from NCI early detection research.
    Verma M; Srivastava S
    Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in biomarker discovery in solid organ transplant by proteomics.
    Sigdel TK; Sarwal MM
    Expert Rev Proteomics; 2011 Dec; 8(6):705-15. PubMed ID: 22087656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
    Sung HJ; Cho JY
    BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
    Srivastava A; Creek DJ
    Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development.
    Mikami T; Aoki M; Kimura T
    Curr Mol Pharmacol; 2012 Jun; 5(2):301-16. PubMed ID: 22122469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A; Jurisica I; Kislinger T
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives.
    Anastasiu CV; Moga MA; Elena Neculau A; Bălan A; Scârneciu I; Dragomir RM; Dull AM; Chicea LM
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
    Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis.
    Ruiz-Romero C; Blanco FJ
    Osteoarthritis Cartilage; 2010 Apr; 18(4):500-9. PubMed ID: 20060947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases.
    Yang J; Roy R; Jedinak A; Moses MA
    Cancer J; 2015; 21(4):327-36. PubMed ID: 26222086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of gliomas: initial biomarker discovery and evolution of technology.
    Kalinina J; Peng J; Ritchie JC; Van Meir EG
    Neuro Oncol; 2011 Sep; 13(9):926-42. PubMed ID: 21852429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current application of proteomics in biomarker discovery for inflammatory bowel disease.
    Chan PP; Wasinger VC; Leong RW
    World J Gastrointest Pathophysiol; 2016 Feb; 7(1):27-37. PubMed ID: 26909226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical application.
    Al-Khalili Szigyarto C
    Expert Rev Proteomics; 2020 May; 17(5):365-375. PubMed ID: 32713262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Predictive Biomarkers in Cancer.
    Nair M; Sandhu SS; Sharma AK
    Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.